Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PCDH7 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | STAU2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | NUDT11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ACP6 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | BOD1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | NLRC3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | TTC37 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | ANKRD29 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | NKX6-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |